Previous Close | $2.00 |
Intrinsic Value | $3.07 |
Upside potential | +53% |
Data is not available at this time.
Atlantic American Corporation operates as an insurance holding company specializing in life and health insurance, as well as property and casualty insurance through its subsidiaries, American Southern Insurance Company and Bankers Fidelity Life Insurance Company. The company primarily serves niche markets in the southeastern United States, offering tailored insurance products to individuals and small businesses. Its revenue model is driven by premium income, investment returns, and underwriting profits, with a focus on maintaining a balanced risk portfolio. Atlantic American competes in a highly fragmented industry, where its regional expertise and conservative underwriting practices provide a competitive edge. While not a market leader, the company maintains a stable presence by leveraging long-standing customer relationships and localized distribution channels. The insurance sector's cyclical nature and regulatory complexity pose challenges, but Atlantic American's disciplined approach to risk management supports its resilience.
In FY 2024, Atlantic American reported revenue of $188.2 million but recorded a net loss of $4.3 million, reflecting underwriting challenges or investment headwinds. The diluted EPS of -$0.19 underscores profitability pressures, though operating cash flow of $4.8 million suggests some operational liquidity. Capital expenditures were minimal at $225,000, indicating low reinvestment needs, typical for an asset-light insurance business.
The company's negative net income and EPS highlight near-term earnings weakness, likely tied to claims volatility or unfavorable investment yields. With modest operating cash flow relative to revenue, capital efficiency appears constrained. However, the low capex intensity suggests earnings potential could improve if underwriting margins stabilize or investment income recovers.
Atlantic American holds $35.6 million in cash against $37.8 million of total debt, indicating a balanced liquidity position. The debt level is manageable given the company's insurance float and recurring premium income. Shareholders' equity remains a key buffer, though the FY 2024 net loss may have eroded it slightly. Solvency metrics appear adequate for its regulated industry.
The company's top-line growth is muted, with profitability trends negative in FY 2024. Atlantic American maintains a modest dividend of $0.04 per share, signaling commitment to shareholders despite earnings volatility. Historical performance suggests cyclicality rather than secular decline, but sustained improvement in underwriting or investment income will be critical for future growth.
Trading at a low absolute share price, the market likely discounts Atlantic American's small scale and recent losses. The dividend yield may attract income-focused investors, but valuation multiples remain subdued due to inconsistent profitability. Investor expectations appear tempered, with limited premium assigned to growth or operational turnaround potential.
Atlantic American's regional focus and conservative underwriting provide stability in a competitive industry. Near-term challenges persist, but its niche positioning and strong regulatory compliance offer a foundation for recovery. The outlook hinges on improved underwriting discipline and investment performance, though macroeconomic factors like interest rates and claims frequency will heavily influence results.
Company filings (10-K), CIK 0000008177
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |